Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation.

Functional crosstalk between G protein-coupled receptors in a homo- or heterodimeric assembly likely involves conformational changes at the dimer interface, but the nature of this interface is not yet established, and the dynamic changes have not yet been identified. We have mapped the homodimer interface in the dopamine D2 receptor over the entire length of the fourth transmembrane segment (TM4) by crosslinking of substituted cysteines. Their susceptibilities to crosslinking are differentially altered by the presence of agonists and inverse agonists. The TM4 dimer interface in the inverse agonist-bound conformation is consistent with the dimer of the inactive form of rhodopsin modeled with constraints from atomic force microscopy. Crosslinking of a different set of cysteines in TM4 was slowed by inverse agonists and accelerated in the presence of agonists; crosslinking of the latter set locks the receptor in an active state. Thus, a conformational change at the TM4 dimer interface is part of the receptor activation mechanism.

[1]  D. A. Brown,et al.  GABAB2 Is Essential for G-Protein Coupling of the GABAB Receptor Heterodimer , 2001, The Journal of Neuroscience.

[2]  Lakshmi A. Devi,et al.  Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy , 2000, The Journal of Neuroscience.

[3]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[4]  P. Strange,et al.  Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors , 1997, British journal of pharmacology.

[5]  Krzysztof Palczewski,et al.  A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[6]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[7]  H. Nakata,et al.  Heteromeric association creates a P2Y-like adenosine receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[9]  J. Banères,et al.  Cooperative Conformational Changes in a G-protein-coupled Receptor Dimer, the Leukotriene B4 Receptor BLT1* , 2004, Journal of Biological Chemistry.

[10]  J. Klco,et al.  C5a Receptor Oligomerization , 2003, Journal of Biological Chemistry.

[11]  P. Delagrange,et al.  Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers , 2004, Molecular Pharmacology.

[12]  B. O'dowd,et al.  Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal* , 2004, Journal of Biological Chemistry.

[13]  J. Ballesteros,et al.  The Forgotten Serine , 2000, The Journal of Biological Chemistry.

[14]  K. Neve,et al.  Contribution of serine residues to constitutive and agonist-induced signaling via the D2S dopamine receptor: evidence for multiple, agonist-specific active conformations. , 1998, Molecular pharmacology.

[15]  L. Prézeau,et al.  Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. , 2003, Pharmacology & therapeutics.

[16]  M. Parmentier,et al.  Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers , 2005, Molecular Pharmacology.

[17]  J. Javitch,et al.  The Human Dopamine Transporter Forms a Tetramer in the Plasma Membrane , 2003, Journal of Biological Chemistry.

[18]  Alfonso Valencia,et al.  Identification of amino acid residues crucial for chemokine receptor dimerization , 2004, Nature Immunology.

[19]  P. Seeman,et al.  Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.

[20]  B. Gowen,et al.  Three-dimensional structure of an invertebrate rhodopsin and basis for ordered alignment in the photoreceptor membrane. , 2001, Journal of molecular biology.

[21]  Graeme Milligan,et al.  G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.

[22]  Marta Filizola,et al.  Structural models for dimerization of G-protein coupled receptors: the opioid receptor homodimers. , 2002, Biopolymers.

[23]  U. Gether Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.

[24]  A. Engel,et al.  Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.

[25]  Yoshihiro Kubo,et al.  Ligand-induced rearrangement of the dimeric metabotropic glutamate receptor 1α , 2004, Nature Structural &Molecular Biology.

[26]  R. Mailman,et al.  Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology , 2003, Neuropsychopharmacology.

[27]  B. O'dowd,et al.  D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. , 2003, Biochemistry.

[28]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[29]  L. Prézeau,et al.  Closed state of both binding domains of homodimeric mGlu receptors is required for full activity , 2004, Nature Structural &Molecular Biology.

[30]  N. Kunishima,et al.  Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+ , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Joseph Parello,et al.  Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. , 2003, Journal of molecular biology.

[32]  L. Prézeau,et al.  Allosteric interactions between GB1 and GB2 subunits are required for optimal GABAB receptor function , 2001, The EMBO journal.

[33]  L. Prézeau,et al.  The intracellular loops of the GB2 subunit are crucial for G-protein coupling of the heteromeric gamma-aminobutyrate B receptor. , 2002, Molecular pharmacology.

[34]  J. Ballesteros,et al.  The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle. , 2000, Biochemistry.

[35]  H. Kandori,et al.  Structural changes in lumirhodopsin and metarhodopsin I studied by their photoreactions at 77 K. , 2003, Biochemistry.

[36]  S. Schuldiner,et al.  Crosslinking of membrane-embedded cysteines reveals contact points in the EmrE oligomer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Krzysztof Palczewski,et al.  Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.

[38]  Krzysztof Palczewski,et al.  Oligomerization of G protein-coupled receptors: past, present, and future. , 2004, Biochemistry.

[39]  S. Swillens,et al.  Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity , 2005, The EMBO journal.

[40]  Michel Bouvier,et al.  Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers* , 2005, Journal of Biological Chemistry.

[41]  T. Mielke,et al.  Electron crystallography reveals the structure of metarhodopsin I , 2004, The EMBO journal.

[42]  K. Nakanishi,et al.  Movement of retinal along the visual transduction path. , 2000, Science.

[43]  B. O'dowd,et al.  D1 and D2 Dopamine Receptors Form Heterooligomers and Cointernalize after Selective Activation of Either Receptor , 2005, Molecular Pharmacology.

[44]  Marta Filizola,et al.  The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design. , 2005, Current opinion in drug discovery & development.

[45]  Julie Perroy,et al.  A Single Subunit (GB2) Is Required for G-protein Activation by the Heterodimeric GABAB Receptor* , 2002, The Journal of Biological Chemistry.

[46]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[47]  M. Bouvier,et al.  Roles of G‐protein‐coupled receptor dimerization , 2004, EMBO reports.

[48]  P. Conn,et al.  Cis- and trans-activation of hormone receptors: the LH receptor. , 2002, Molecular endocrinology.

[49]  Lei Shi,et al.  The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer* , 2003, The Journal of Biological Chemistry.

[50]  Michel Bouvier,et al.  Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.

[51]  Lei Shi,et al.  The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. , 2002, Annual review of pharmacology and toxicology.

[52]  M. Jeoung,et al.  Trans-activation of mutant follicle-stimulating hormone receptors selectively generates only one of two hormone signals. , 2004, Molecular endocrinology.

[53]  S. Nakanishi,et al.  Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.